Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.7K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.7K
Biostatistics: Overview01:20

Biostatistics: Overview

648
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
648
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.1K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming insulin receptor activation with a de novo agonist to overcome severe insulin resistance.

bioRxiv : the preprint server for biology·2026
Same author

Clinical trials for continuously monitored and updated AI systems.

Nature medicine·2026
Same author

Physician Characteristics Associated With Advance Care Planning After a Machine Learning-Based Nudge.

The American journal of hospice & palliative care·2025
Same author

Eliminating the AI digital divide by building local capacity.

PLOS digital health·2025
Same author

Tuning insulin receptor signaling using de novo-designed agonists.

Molecular cell·2025
Same author

Single Leaflet Device Attachment After Pascal Implantation for Transcatheter Edge-to-Edge Repair: Systematic Review and Meta-Analysis.

Structural heart : the journal of the Heart Team·2025

Related Experiment Video

Updated: Dec 25, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.1K

Presenting machine learning model information to clinical end users with model facts labels.

Mark P Sendak1, Michael Gao1, Nathan Brajer1,2

  • 11Duke Institute for Health Innovation, Durham, NC USA.

NPJ Digital Medicine
|March 29, 2020
PubMed
Summary

A new "Model Facts" label aims to inform clinicians about using machine learning (ML) in patient care. This ensures safe and effective integration of ML diagnostic and prognostic tools into clinical practice.

Keywords:
Health policyHealth servicesTranslational research

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Dec 25, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.1K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Medical Informatics
  • Clinical Decision Support Systems
  • Machine Learning in Healthcare

Background:

  • Machine learning (ML) shows promise for enhancing medical diagnosis and prognosis.
  • Clinical end-users often lack awareness of potential patient harm from ML models.
  • Translating ML models into clinical practice presents significant risks.

Purpose of the Study:

  • To introduce the "Model Facts" label for clear communication of ML model information.
  • To ensure clinicians understand how and when to use ML model outputs.
  • To mitigate risks associated with ML model integration in healthcare.

Main Methods:

  • Proposal of a systematic "Model Facts" labeling system.
  • Designed as a 1-page collation of relevant, actionable information for clinicians.
  • Emphasizes collaboration between practitioners and regulators for standardization.

Main Results:

  • The "Model Facts" label provides essential information for clinical decision-making.
  • Standardized presentation of ML model information can prevent patient harm.
  • Clear communication is crucial for the safe adoption of ML tools.

Conclusions:

  • The "Model Facts" label is a vital tool for safe ML integration in clinical settings.
  • Standardization of ML information presentation is necessary for patient safety.
  • Collaborative efforts are required to implement and standardize ML model communication.